• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Comprehensive Overview of (R)-α-Amino-4-hydroxy-Benzeneacetic Acid 2-Hydroxyethyl Ester (CAS No. 203007-73-2)

(R)-α-Amino-4-hydroxy-Benzeneacetic Acid 2-Hydroxyethyl Ester, with the CAS number 203007-73-2, is a specialized chiral compound widely utilized in pharmaceutical research, organic synthesis, and biochemical applications. This ester derivative of α-amino-4-hydroxy-benzeneacetic acid is particularly valued for its enantiomeric purity ((R)-configuration) and functional versatility. Its molecular structure combines a hydroxyethyl ester group with a para-hydroxyphenyl moiety, making it a key intermediate in the synthesis of optically active compounds.

The growing demand for chiral building blocks in drug development has positioned (R)-α-Amino-4-hydroxy-Benzeneacetic Acid 2-Hydroxyethyl Ester as a compound of significant interest. Researchers frequently search for "CAS 203007-73-2 applications" or "(R)-enantiomer synthesis methods," reflecting its relevance in asymmetric catalysis and peptide mimetics. Its hydroxyethyl ester group enhances solubility, a critical factor in formulation studies, while the para-hydroxy substitution offers reactivity for further derivatization.

In the context of trending topics like "green chemistry" and "sustainable synthesis," this compound aligns with efforts to reduce waste in chiral auxiliaries. Its enantioselective preparation often involves biocatalysis or metal-free methodologies, addressing concerns about heavy metal residues in pharmaceuticals. Analytical techniques such as HPLC chiral separation and NMR stereochemical analysis are commonly employed to verify its optical purity, topics frequently queried in academic databases.

The compound's benzeneacetic acid backbone shares structural similarities with nonsteroidal anti-inflammatory drug (NSAID) precursors, sparking research into its potential as a bioactive scaffold. However, unlike regulated substances, 203007-73-2 serves purely as a research chemical without scheduled status. Patent literature highlights its utility in creating peptidomimetics for metabolic stability enhancement—a hot topic in "oral bioavailability optimization" searches.

From a technical perspective, storage conditions for (R)-α-Amino-4-hydroxy-Benzeneacetic Acid 2-Hydroxyethyl Ester typically require protection from light and moisture due to its phenolic hydroxyl sensitivity—a detail often overlooked in "CAS 203007-73-2 handling" queries. Its melting point range (often 120-125°C) and spectral data (characteristic IR carbonyl stretch at ~1740 cm?1) provide identification benchmarks crucial for quality control in contract manufacturing organizations (CMOs).

Emerging applications in fluorescent probes leverage its aromatic system, with modifications at the 4-hydroxy position enabling pH-sensitive designs. This intersects with the booming field of "diagnostic imaging agents," where researchers seek novel benzeneacetic acid derivatives. The compound's ester hydrolysis kinetics also make it a model substrate for enzyme mechanism studies, particularly in "serine hydrolase" research.

Regulatory-compliant suppliers provide 203007-73-2 with detailed certificates of analysis (CoA), including chiral HPLC purity (>98% ee) and residual solvent profiles—key documentation requested in "pharma-grade reagents" procurement. Scale-up challenges for this optically active ester often involve minimizing racemization during O-alkylation steps, a technical hurdle documented in process chemistry forums.

In material science, the compound's hydrogen-bonding capacity through its amino and hydroxy groups enables crystal engineering applications. This property aligns with searches for "supramolecular synthons" in crystal structure prediction. Thermal analysis (DSC/TGA) of (R)-α-Amino-4-hydroxy-Benzeneacetic Acid 2-Hydroxyethyl Ester reveals distinct polymorphic transitions, data increasingly valuable for "preformulation studies" in solid dosage development.

The scientific community continues to explore novel synthetic routes to 203007-73-2, including continuous flow chemistry approaches that improve atom economy—a response to "flow synthesis advantages" queries. Its role as a precursor to unnatural amino acids connects with biotechnology trends, particularly in "non-canonical amino acid incorporation" for protein engineering.

• 37763-23-8(Methyl D-(-)-4-Hydroxy-phenylglycinate)
• 43189-12-4(METHYL 2-AMINO-2-(4-HYDROXYPHENYL)ACETATE)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)